For example, the inhibition of TSLP, an inhibitory target of atopic dermatitis, was predicted to lead to therapeutic effects in cervical cancer (CC), ovarian cancer (OC), systemic lupus erythematosus (SLE), chronic myeloid leukemia (CML) and congenital muscular dystrophies. This evidence concerns the gene TSLP and cervical carcinoma.